The lung cancer breathalyzer can detect pulmonary tumour growth before it becomes too late. Lung cancer is usually not diagnosed until serious symptoms develop.
Diagnosing lung cancer may soon become as easy as detecting bad breath. The University of Huddersfield-led research team have recently launched a 3-year project aimed at creating a lung cancer breathalyzer device that can detect early signs of cancer.
Lung cancer is uncontrolled cell growth in the tissues of one’s lung. If left untreated, the abnormal growth can spread to nearby tissue or even other parts of one’s body through metastasis.
The symptoms of lung cancer are:
- Raspy cough
- Coughing up blood
- Difficulty swallowing
- Unexplained weight loss
- Recurrent respiratory infections
- Shortness of breath
- Swelling of face and neck
- Intermittent fever, body pain
Due to delayed diagnosis, the death toll from lung cancer remains high. Just like cancer of the pancreas, colon and rectum, lung cancer too does not manifest itself symptomatically until the tumour growth has reached an advanced stage and has spread to the neighbouring tissue through metastasis. At this stage it becomes exceedingly difficult for any surgical & medical intervention.
The lung cancer breathalyzer aims to fix this by spotting biomarkers of lung cancer – subtle chemical fluctuations & signatures suggesting presence of cancerous tissue in one’s lungs. Researchers believe that such biomarkers could be detected using a sensitive breath tester. The intention is to detect lung cancer in patients before the symptoms develop. Once patients start experiencing lung cancer symptoms it’s often quite advanced and chances of curing it are low.
Pharmacists will soon be able to administer the breath test that holds the potential to save the lives of hundreds of thousands of lung cancer patients. The breathalyser device ensures early lung cancer detection and dramatically increases survival chances.